Managing rheumatic and musculoskeletal diseases — past, present and future
- 15 June 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 13 (7), 443-448
- https://doi.org/10.1038/nrrheum.2017.95
Abstract
Progress in rheumatology has been remarkable in the past 70 years, favourably affecting quality of life for people with rheumatic and musculoskeletal diseases. Therapeutics have advanced considerably in this period, from early developments such as the introduction of glucocorticoid therapy to the general use of methotrexate and other disease-modifying agents, followed by the advent of biologic DMARDs and, most recently, small-molecule signalling inhibitors. Novel strategies for the use of such agents have also transformed outcomes, as have multidisciplinary nonpharmacological approaches to the management of rheumatic musculoskeletal disease including surgery, physical therapy and occupational therapy. Breakthroughs in our understanding of disease pathogenesis, diagnostics and the use of 'big data' continue to drive the field forward. Critically, the patient is now at the centre of management strategies as well as the future research agenda.Keywords
This publication has 43 references indexed in Scilit:
- Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritisVideosurgery and Other Miniinvasive Techniques, 2011
- Assessing microvascular changes in systemic sclerosis diagnosis and managementNature Reviews Rheumatology, 2010
- History of Neuroimaging: The Legacy of William OldendorfJournal of Child Neurology, 2010
- Rheumatoid factor revisitedCurrent Opinion in Rheumatology, 2004
- Guidelines for musculoskeletal ultrasound in rheumatologyAnnals Of The Rheumatic Diseases, 2001
- Editorial Overview: Antinuclear Antibody- and Extractable Nuclear Antigen-Related DiseasesInternational Archives of Allergy and Immunology, 2000
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisThe New England Journal of Medicine, 1985
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985
- Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopyArthritis & Rheumatism, 1973
- Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations.Acta Medica Scandinavica, 1942